Kuznicki Law PLLC notifies investors that a class action has commenced in the United States District Court for the Northern District of Illinois on behalf of shareholders of Tempus AI, Inc. who purchased shares between August 6, 2024 and May 27, 2025.
Tempus and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 28, 2025, Spruce Point Capital Management, LLC reported numerous issues with the Company’s management, operations and financial reporting, including that: (i) Tempus CEO Eric Lefkofsky and his associates have a history cashing out of companies before public shareholders incur losses or lackluster returns; (ii) Tempus’ actual AI capabilities are overstated; (iii) board members and other executives have been associated with troubled companies with restated financial results; (iv) signs of aggressive accounting and financial reporting are present; (v) there are issues with the AstraZeneca and Pathos AI deal that merit scrutiny; and (vi) the Company’s recent financial guidance revision reveals weakness in core operations.
On this news, the price of Tempus’ shares fell $12.67 per share, or 19.23%, from a closing price of $65.87 per share on May 27, 2025, to a closing price of $53.20 per share on May 28, 2025.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until August 12, 2025 to request that the court appoint them lead plaintiff.